PROEHL GERALD T 13D/13G Filings for Dermata Therapeutics, Inc. (DRMA)

PROEHL GERALD T 13D and 13G filings for Dermata Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-07
9:37 pm
Purchase
2025-03-27 13D Dermata Therapeutics, Inc.
DRMA
PROEHL GERALD T 804,098
13.300%
804,098increase
(New Position)
Filing